Average Co-Inventor Count = 8.01
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (11 from 3,923 patents)
2. Chiron Corporation (10 from 672 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (9 from 245 patents)
30 patents:
1. 10112931 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
2. 9688672 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
3. 9546173 - Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors
4. 9434719 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
5. 8957068 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
6. 8865732 - Heterocyclic compounds and uses thereof
7. 8822497 - PIM kinase inhibitors and methods of their use
8. 8614330 - Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
9. 8592459 - Substituted benzimidazoles and methods of their use
10. 8415382 - Substituted benzazoles and methods of their use as inhibitors of RAF Kinase
11. 8129394 - Heteroaryl-substituted imidazole compounds and uses thereof
12. 7732465 - Substituted benzimidazoles and methods of their use
13. 7728010 - Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
14. 7671059 - 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-ones
15. 7642278 - Indazole benzimidazole compounds